Tumor-specific circulating cell-free DNA (ctDNA) and its clinical value in predicting response to palliative systemic treatment or survival in patients with pancreatic cancer: A systematic review and meta-analysis

M.M. Steiniche; L.B. Callesen; E.H. Vlk; R.F. Andersen; T.F. Hansen; M. Ladekarl; K-L.G. Spindler

doi:10.1016/j.annonc.2024.08.1571

Tumor-specific circulating cell-free DNA (ctDNA) and its clinical value in predicting response to palliative systemic treatment or survival in patients with pancreatic cancer: A systematic review and meta-analysis

M.M. Steiniche, L.B. Callesen, E.H. Vlk, R.F. Andersen, T.F. Hansen, M. Ladekarl, K-L.G. Spindler

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning

Originalsprog	Engelsk
Artikelnummer	1508P
Tidsskrift	Annals of Oncology
Vol/bind	35
Udgave nummer	Suppl. 2
Sider (fra-til)	S923-S924
Antal sider	2
ISSN	0923-7534
DOI	https://doi.org/10.1016/j.annonc.2024.08.1571
Status	Udgivet - sep. 2024
Begivenhed	ESMO Congress 2024 - Barcelona, Spanien Varighed: 13 sep. 2024 → 17 sep. 2024 https://oncologypro.esmo.org/meeting-resources/esmo-congress-2024

Konference

Konference	ESMO Congress 2024
Land/Område	Spanien
By	Barcelona
Periode	13/09/2024 → 17/09/2024
Internetadresse	https://oncologypro.esmo.org/meeting-resources/esmo-congress-2024

Bibliografisk note

Abstrakt No. 1508P

Adgang til dokumentet

10.1016/j.annonc.2024.08.1571

https://linkinghub.elsevier.com/retrieve/pii/S0923753424030904

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

Steiniche, M. M., Callesen, L. B., Vlk, E. H., Andersen, R. F., Hansen, T. F., Ladekarl, M., & Spindler, K.-LG. (2024). Tumor-specific circulating cell-free DNA (ctDNA) and its clinical value in predicting response to palliative systemic treatment or survival in patients with pancreatic cancer: A systematic review and meta-analysis. Annals of Oncology, 35(Suppl. 2), S923-S924. Artikel 1508P. https://doi.org/10.1016/j.annonc.2024.08.1571

@article{2e39df6a15b64c51bb021afe19d9a624,

title = "Tumor-specific circulating cell-free DNA (ctDNA) and its clinical value in predicting response to palliative systemic treatment or survival in patients with pancreatic cancer: A systematic review and meta-analysis",

author = "M.M. Steiniche and L.B. Callesen and E.H. Vlk and R.F. Andersen and T.F. Hansen and M. Ladekarl and K-L.G. Spindler",

note = "Abstract No. 1508P; ESMO Congress 2024 ; Conference date: 13-09-2024 Through 17-09-2024",

year = "2024",

month = sep,

doi = "10.1016/j.annonc.2024.08.1571",

language = "English",

volume = "35",

pages = "S923--S924",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier",

number = "Suppl. 2",

url = "https://oncologypro.esmo.org/meeting-resources/esmo-congress-2024",

}

Steiniche, MM, Callesen, LB, Vlk, EH, Andersen, RF, Hansen, TF, Ladekarl, M & Spindler, K-LG 2024, 'Tumor-specific circulating cell-free DNA (ctDNA) and its clinical value in predicting response to palliative systemic treatment or survival in patients with pancreatic cancer: A systematic review and meta-analysis', Annals of Oncology, bind 35, nr. Suppl. 2, 1508P, s. S923-S924. https://doi.org/10.1016/j.annonc.2024.08.1571

Tumor-specific circulating cell-free DNA (ctDNA) and its clinical value in predicting response to palliative systemic treatment or survival in patients with pancreatic cancer: A systematic review and meta-analysis. / Steiniche, M.M.; Callesen, L.B.; Vlk, E.H. et al.
I: Annals of Oncology, Bind 35, Nr. Suppl. 2, 1508P, 09.2024, s. S923-S924.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning

TY - ABST

T1 - Tumor-specific circulating cell-free DNA (ctDNA) and its clinical value in predicting response to palliative systemic treatment or survival in patients with pancreatic cancer: A systematic review and meta-analysis

AU - Steiniche, M.M.

AU - Callesen, L.B.

AU - Vlk, E.H.

AU - Andersen, R.F.

AU - Hansen, T.F.

AU - Ladekarl, M.

AU - Spindler, K-L.G.

N1 - Abstract No. 1508P

PY - 2024/9

Y1 - 2024/9

U2 - 10.1016/j.annonc.2024.08.1571

DO - 10.1016/j.annonc.2024.08.1571

M3 - Conference abstract in journal

SN - 0923-7534

VL - 35

SP - S923-S924

JO - Annals of Oncology

JF - Annals of Oncology

IS - Suppl. 2

M1 - 1508P

T2 - ESMO Congress 2024

Y2 - 13 September 2024 through 17 September 2024

ER -

Steiniche MM, Callesen LB, Vlk EH, Andersen RF, Hansen TF, Ladekarl M et al. Tumor-specific circulating cell-free DNA (ctDNA) and its clinical value in predicting response to palliative systemic treatment or survival in patients with pancreatic cancer: A systematic review and meta-analysis. Annals of Oncology. 2024 sep.;35(Suppl. 2):S923-S924. 1508P. doi: 10.1016/j.annonc.2024.08.1571